2016
DOI: 10.1016/j.ijbiomac.2015.11.031
|View full text |Cite
|
Sign up to set email alerts
|

Dibutyrylchitin nanoparticles as novel drug carrier

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(11 citation statements)
references
References 33 publications
0
9
0
Order By: Relevance
“…This study has shown that AuNPs synthesized from CM extract are hemocompatible. No more than 10% of hemolysis was observed for all tested concentrations up to 50 µg/mL, which is below the safe hemolytic ratio for biomaterials according to ISO/TR7406 [39]. The aggregation of RBC was also not observed for all concentrations of AuNPs tested.…”
Section: Discussionmentioning
confidence: 79%
“…This study has shown that AuNPs synthesized from CM extract are hemocompatible. No more than 10% of hemolysis was observed for all tested concentrations up to 50 µg/mL, which is below the safe hemolytic ratio for biomaterials according to ISO/TR7406 [39]. The aggregation of RBC was also not observed for all concentrations of AuNPs tested.…”
Section: Discussionmentioning
confidence: 79%
“…High NC loading will be important for molecular imaging applications. These DBC particles reported herein had a hydrodynamic diameter larger than other DBC particles reported in the literature; diameter ~ 100 nm [35]. Although in the oil-in-water emulsion process we utilized larger particles were formed, our technique provides an alternative encapsulation strategy for labile drugs and proteins, due to the lower amplitudes and sonication time involved.…”
Section: Discussionmentioning
confidence: 90%
“…While chitin is a promising biomaterial, DBC is also highly biocompatible and it can be degraded by enzymes [35]. Moreover, it has wound-healing and antibacterial properties [36].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding nanotechnology-related drug delivery applications, chitin and its derivatives have attracted remarkable attention from the scientific community. Thus, considering the challenges of current therapies (in terms of drug resistance and systemic or topic side effects) and the processing versatility of chitin-derived compounds, various research studies have reported successful data regarding chitin-based nanostructures for controlled and/or targeted delivery of antibiotics [40,41,42], antivirals [43], antifungals [44,45,46], anti-inflammatory [47,48] and anti-tumor substances [38,43,49,50].…”
Section: Introductionmentioning
confidence: 99%